Example: stock market
AUSTRALIAN PRODUCT INFORMATION APO ... - …
3 Hepatic Insufficiency Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses (see section 4.4 Special warnings and precautions for use).Clopidogrel/Aspirin
Information
Domain:
Source:
Link to this page:
Documents from same domain
DEPOT PREFILLED DUAL-CHAMBER SYRINGE (PDS) …
www.medicines.org.auLucrin Depot Prefilled Dual-Chamber Syringe (PDS) Injection Version 13 12 May 2015 Page 2 of 18 Lucrin Depot 3-Month PDS Injection is available as sterile lyophilised microspheres, which, when
ELEVA - Medicines
www.medicines.org.auELEVA – PRODUCT INFORMATION 3 During prolonged maintenance therapy for any indication, dosage should be kept at the lowest effective level.
Aratac - Medicines
www.medicines.org.auAratac – Product Information 4 case amiodarone should be withdrawn. Recovery usually occurs within a few months following withdrawal of treatment; clinical recovery precedes the normalisation of thyroid function tests.
Deralin - Medicines
www.medicines.org.auDeralin – Product Information 2 The possible mechanism of the antianginal activity of propranolol hydrochloride appears to be due to a reduction in left ventricular work and oxygen utilisation resulting from inhibition of cardiac sympathetic nerve
AUSTRALIAN PRODUCT INFORMATION ... - …
www.medicines.org.auCABOMETYX Product Information V1.0 4 Safety and efficacy of cabozantinib has not been evaluated in patients with NMYHA Class 3 or 4 Heart Failure and patients with endobronchial manifestations of RCC.
Product Information Zyrtec - Medicines
www.medicines.org.auZyrtec PI Page 1 of 8 Australia J&J Pacific 3rd April 2014 1 of 8 Product Information Zyrtec NAME OF THE MEDICINE Cetirizine hydrochloride DESCRIPTION Cetirizine hydrochloride is an orally active, H
PRODUCT INFORMATION Axit - Medicines
www.medicines.org.auAxit – Product Information 3 Geriatric. The recommended dosage regimen is the same as for adults. Increases should be monitored carefully (see DOSAGE AND ADMINISTRATION).
PRODUCT INFORMATION CLOFEN - Medicines
www.medicines.org.auCLOFEN – PRODUCT INFORMATION 2 Pharmacokinetics Absorption Baclofen is rapidly and completely absorbed from the gastrointestinal tract. Maximum concentrations of …
Humira Pen - Medicines
www.medicines.org.auHUMIRA 40MG/0.8ML PEN 16 APRIL 2018 VERSION 24 2 pan-uveitis, an inflammatory disease of the uveal tract of the eye. Humira is used in adults who have not
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au4 PANADOL CHILDREN 1 to 5 YEARS COLOURFREE SUSPENSION AGE AVERAGE WEIGHT DOSE 1 – 2 years 10 - 12 kg 6 - 8 mL 2 – 3 years 12 - 14 kg 8 - 9 mL
Related documents
Emergency Department Core Competencies, Skills Checklist ...
www.bchsys.orgDemonstrate competent use of the ED cardiac bedside monitors, the cen tral station, and the Phillips d efibrillation monitors , application of 3 &/or 5 lead chest ... o Thrombolytics o Analgesics o Sedatives o Neuromuscular blocking agents o Reversal agents .
ACUTE ARTERIAL OCCLUSION
gsm.utmck.eduACUTE ARTERIAL OCCLUSION “ The operation was a success but the patient died” • High Morbidity and Mortality – Emergent operations in high risk patients
PACU RN Skills Checklist - pninursing.com
pninursing.comPACU RN Skills Checklist Page 2 of 4 Provide care for the patient with an IABP 0 1 2 3 Provide care for the patient in shock 0 1 2 3
Medicines Company at 1-800-264-4662 or FDA at 1 ... - …
www.angiomax.com2 . FULL PRESCRIBING INFORMATION. 1 INDICATIONS AND USAGE 1.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Angiomax ® (bivalirudin) is indicated for use as an anticoagulant in patients with unstable angina
HIGHLIGHTS OF PRESCRIBING INFORMATION - Baxter PI
www.baxterpi.com8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established. 8.5 Geriatric Use In studies of patients undergoing PCI, 44% were ≥65 years of age and 12% of patients were ≥75
PRODUCT MONOGRAPH - bayer.ca
www.bayer.caINDICATIONS AND CLINICAL USE ASPIRIN® (acetylsalicylic acid, ASA) is indicated for the relief of pain, fever and inflammation of a variety of conditions such …
Delayed and Omitted Doses of Medicines Procedure
doclibrary-rcht.cornwall.nhs.uk‘information use framework policy’, or contact the Information Governance Team [email protected] 2. Purpose of this Policy/Procedure 2.1 To ensure that missed and delayed doses of medication are accurately recorded in the clinical record. 2.2 Clearly state the expected response to a missed of medicines and